https://multiplesclerosisnewstoday.com/news-posts/2023/06/14/ocrevus-better-rituximab-preventing-ms-relapses-study/
Ocrevus is more effective than rituximab at reducing relapse activity of RRMS, while disability progression is comparable, a study suggests.
Create an account
or login to join the discussion